Ovarian stimulation and endometriosis progression or recurrence: a systematic review

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Available evidence on the impact of ovarian stimulation on the progression of endometriosis or its recurrence was systematically reviewed. Data from ovarian stimulation alone, or associated with intrauterine insemination (IUI) or IVF, were included. Sixteen studies were selected. Initial case reports (n = 11) documented some severe clinical complications. However, subsequent observational studies were more reassuring. Overall, five conclusions can be drawn: (i) IVF does not worsen endometriosis-related pain symptoms (moderate quality evidence); (ii) IVF does not increase the risk of endometriosis recurrence (moderate quality evidence); (iii) the impact of IVF on ovarian endometriomas, if present at all, is mild (low quality evidence); (iv) IUI may increase the risk of endometriosis recurrence (low quality evidence); (v) deep invasive endometriosis might progress with ovarian stimulation (very low quality evidence). In conclusion, available evidence is generally reassuring (at least for IVF) and does not justify aggressive clinical approaches such as prophylactic surgery before assisted reproductive technology treatment to prevent endometriosis progression or recurrence. However, further evidence is required before being able to reach definitive conclusions. In particular, the potential effects on deep invasive endometriosis and the possible synergistic effect of stimulation and pregnancy are two areas that need to be explored further.

Original languageEnglish
Pages (from-to)185-194
Number of pages10
JournalReproductive BioMedicine Online
Volume38
Issue number2
DOIs
Publication statusPublished - Feb 1 2019

Fingerprint

Ovulation Induction
Endometriosis
Recurrence
Insemination
Assisted Reproductive Techniques
Observational Studies
Pain
Pregnancy

Keywords

  • Endometriosis
  • Intrauterine insemination
  • IVF
  • Ovarian stimulation
  • Recurrence

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology
  • Developmental Biology

Cite this

Ovarian stimulation and endometriosis progression or recurrence : a systematic review. / Somigliana, Edgardo; Viganò, Paola; Benaglia, Laura; Busnelli, Andrea; Paffoni, Alessio; Vercellini, Paolo.

In: Reproductive BioMedicine Online, Vol. 38, No. 2, 01.02.2019, p. 185-194.

Research output: Contribution to journalReview article

@article{fcf8a9ffd8b14fb69b615199ff4af9fe,
title = "Ovarian stimulation and endometriosis progression or recurrence: a systematic review",
abstract = "Available evidence on the impact of ovarian stimulation on the progression of endometriosis or its recurrence was systematically reviewed. Data from ovarian stimulation alone, or associated with intrauterine insemination (IUI) or IVF, were included. Sixteen studies were selected. Initial case reports (n = 11) documented some severe clinical complications. However, subsequent observational studies were more reassuring. Overall, five conclusions can be drawn: (i) IVF does not worsen endometriosis-related pain symptoms (moderate quality evidence); (ii) IVF does not increase the risk of endometriosis recurrence (moderate quality evidence); (iii) the impact of IVF on ovarian endometriomas, if present at all, is mild (low quality evidence); (iv) IUI may increase the risk of endometriosis recurrence (low quality evidence); (v) deep invasive endometriosis might progress with ovarian stimulation (very low quality evidence). In conclusion, available evidence is generally reassuring (at least for IVF) and does not justify aggressive clinical approaches such as prophylactic surgery before assisted reproductive technology treatment to prevent endometriosis progression or recurrence. However, further evidence is required before being able to reach definitive conclusions. In particular, the potential effects on deep invasive endometriosis and the possible synergistic effect of stimulation and pregnancy are two areas that need to be explored further.",
keywords = "Endometriosis, Intrauterine insemination, IVF, Ovarian stimulation, Recurrence",
author = "Edgardo Somigliana and Paola Vigan{\`o} and Laura Benaglia and Andrea Busnelli and Alessio Paffoni and Paolo Vercellini",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.rbmo.2018.11.021",
language = "English",
volume = "38",
pages = "185--194",
journal = "Reproductive BioMedicine Online",
issn = "1472-6483",
publisher = "Elsevier Ltd",
number = "2",

}

TY - JOUR

T1 - Ovarian stimulation and endometriosis progression or recurrence

T2 - a systematic review

AU - Somigliana, Edgardo

AU - Viganò, Paola

AU - Benaglia, Laura

AU - Busnelli, Andrea

AU - Paffoni, Alessio

AU - Vercellini, Paolo

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Available evidence on the impact of ovarian stimulation on the progression of endometriosis or its recurrence was systematically reviewed. Data from ovarian stimulation alone, or associated with intrauterine insemination (IUI) or IVF, were included. Sixteen studies were selected. Initial case reports (n = 11) documented some severe clinical complications. However, subsequent observational studies were more reassuring. Overall, five conclusions can be drawn: (i) IVF does not worsen endometriosis-related pain symptoms (moderate quality evidence); (ii) IVF does not increase the risk of endometriosis recurrence (moderate quality evidence); (iii) the impact of IVF on ovarian endometriomas, if present at all, is mild (low quality evidence); (iv) IUI may increase the risk of endometriosis recurrence (low quality evidence); (v) deep invasive endometriosis might progress with ovarian stimulation (very low quality evidence). In conclusion, available evidence is generally reassuring (at least for IVF) and does not justify aggressive clinical approaches such as prophylactic surgery before assisted reproductive technology treatment to prevent endometriosis progression or recurrence. However, further evidence is required before being able to reach definitive conclusions. In particular, the potential effects on deep invasive endometriosis and the possible synergistic effect of stimulation and pregnancy are two areas that need to be explored further.

AB - Available evidence on the impact of ovarian stimulation on the progression of endometriosis or its recurrence was systematically reviewed. Data from ovarian stimulation alone, or associated with intrauterine insemination (IUI) or IVF, were included. Sixteen studies were selected. Initial case reports (n = 11) documented some severe clinical complications. However, subsequent observational studies were more reassuring. Overall, five conclusions can be drawn: (i) IVF does not worsen endometriosis-related pain symptoms (moderate quality evidence); (ii) IVF does not increase the risk of endometriosis recurrence (moderate quality evidence); (iii) the impact of IVF on ovarian endometriomas, if present at all, is mild (low quality evidence); (iv) IUI may increase the risk of endometriosis recurrence (low quality evidence); (v) deep invasive endometriosis might progress with ovarian stimulation (very low quality evidence). In conclusion, available evidence is generally reassuring (at least for IVF) and does not justify aggressive clinical approaches such as prophylactic surgery before assisted reproductive technology treatment to prevent endometriosis progression or recurrence. However, further evidence is required before being able to reach definitive conclusions. In particular, the potential effects on deep invasive endometriosis and the possible synergistic effect of stimulation and pregnancy are two areas that need to be explored further.

KW - Endometriosis

KW - Intrauterine insemination

KW - IVF

KW - Ovarian stimulation

KW - Recurrence

UR - http://www.scopus.com/inward/record.url?scp=85059313493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059313493&partnerID=8YFLogxK

U2 - 10.1016/j.rbmo.2018.11.021

DO - 10.1016/j.rbmo.2018.11.021

M3 - Review article

C2 - 30609970

AN - SCOPUS:85059313493

VL - 38

SP - 185

EP - 194

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

SN - 1472-6483

IS - 2

ER -